Michael A. Sanzo

Michael A. Sanzo is a patent attorney with a robust background primarily focused on biotechnology, chemistry, and pharmaceuticals. His practice emphasizes patent prosecution, opinions, and intellectual property strategy, leveraging his prior experience as a scientist at Monsanto Company and his Ph.D. in Biochemistry. Mr. Sanzo has an inventor on issued U.S. patents and has experience with AI-assisted invention development.

While his practice largely centers on patent prosecution for pharmaceutical and chemical companies, universities, and teaching hospitals, and he has obtained between 350 and 400 patents for clients, his tracked patent litigation experience includes one appearance on the plaintiff side in Microsoft Corporation v. X1 Discovery, Inc.

Mr. Sanzo operates his practice through the Law Office of Michael A. Sanzo, LLC, which is also noted as a division of Capital City TechLaw. Before establishing his solo practice, he gained experience at several large law firms, including Sterne, Kessler, Goldstein and Fox; Vinson and Elkins; Pillsbury Winthrop; and Fitch, Even, Tabin & Flannery. The available information does not specify regular appearances in PTAB or IPR proceedings.

He earned his Ph.D. in Biochemistry and completed a postdoctoral fellowship at Baylor College of Medicine. He obtained his Juris Doctor (cum laude) from St. Louis University in 1992 and is a registered patent attorney.